BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16240879)

  • 1. [Sickle cell disease: exotic disease or a Belgian public health problem?].
    Gulbis B; Ferster A; Kentos A; N'Gay Munungi D; Cotton F; Rongé E; Dresse MF; Bradstreet C; Cochaux P; Vertongen F
    Rev Med Brux; 2005 Sep; 26(4):S309-13. PubMed ID: 16240879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies.
    Tshilolo L; Kafando E; Sawadogo M; Cotton F; Vertongen F; Ferster A; Gulbis B
    Public Health; 2008 Sep; 122(9):933-41. PubMed ID: 18555498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal haemoglobinopathy screening in Belgium.
    Gulbis B; Cotton F; Ferster A; Ketelslegers O; Dresse MF; Rongé-Collard E; Minon JM; Lé PQ; Vertongen F
    J Clin Pathol; 2009 Jan; 62(1):49-52. PubMed ID: 19103861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal haemoglobinopathy screening: review of a 10-year programme in Brussels.
    Gulbis B; Ferster A; Cotton F; Lebouchard MP; Cochaux P; Vertongen F
    J Med Screen; 2006; 13(2):76-8. PubMed ID: 16792829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of haemoglobinopathies detected through neonatal screening in the United Arab Emirates.
    Al Hosani H; Salah M; Osman HM; Farag HM; Anvery SM
    East Mediterr Health J; 2005 May; 11(3):300-7. PubMed ID: 16602448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for sickle cell disease on dried blood: a new approach evaluated on 27,000 Belgian newborns.
    Boemer F; Vanbellinghen JF; Bours V; Schoos R
    J Med Screen; 2006; 13(3):132-6. PubMed ID: 17007654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recognition of children with sickle cell disease in The Netherlands].
    Heijboer H; Van den Tweel XW; Fijnvandraat K; Peters M
    Ned Tijdschr Geneeskd; 2007 Nov; 151(45):2498-501. PubMed ID: 18062592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal screening for sickle cell disorders in Ouagadougou, Burkina Faso: a pilot study.
    Kafando E; Sawadogo M; Cotton F; Vertongen F; Gulbis B
    J Med Screen; 2005; 12(3):112-4. PubMed ID: 16156939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sickle cell disease from Africa to Belgium, from neonatal screening to clinical management.
    Lê PQ; Ferster A; Cotton F; Vertongen F; Vermylen C; Vanderfaeillie A; Dedeken L; Heijmans C; Ketelslegers O; Dresse MF; Gulbis B
    Med Trop (Mars); 2010 Dec; 70(5-6):467-70. PubMed ID: 21516988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn screening follow-up within the lifespan context: Michigan's experience.
    Grigorescu V; Kleyn MJ; Korzeniewski SJ; Young WI; Whitten-Shurney W
    Am J Prev Med; 2010 Apr; 38(4 Suppl):S522-7. PubMed ID: 20331953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neonatal detection of sickle cell disease].
    Bardakdjian-Michau J
    J Gynecol Obstet Biol Reprod (Paris); 2003 Feb; 32(1 Suppl):1S61-4. PubMed ID: 12592166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red blood cell disorders in Rwandese neonates: screening for sickle cell disease and glucose-6-phosphate dehydrogenase deficiency.
    Munyanganizi R; Cotton F; Vertongen F; Gulbis B
    J Med Screen; 2006; 13(3):129-31. PubMed ID: 17007653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Abnormal haemoglobins in the newborn human population of Costa Rica].
    Abarca G; Navarrete M; Trejos R; de Céspedes C; Saborío M
    Rev Biol Trop; 2008 Sep; 56(3):995-1001. PubMed ID: 19419022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The problem of sickle cell disease in Africa].
    Labie D; Elion J
    Med Trop (Mars); 2010 Dec; 70(5-6):449-53. PubMed ID: 21520645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal screening for sickle cell disease in France.
    Bardakdjian-Michau J; Bahuau M; Hurtrel D; Godart C; Riou J; Mathis M; Goossens M; Badens C; Ducrocq R; Elion J; Perini JM
    J Clin Pathol; 2009 Jan; 62(1):31-3. PubMed ID: 19103855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal/newborn haemoglobinopathy screening in Europe and Africa.
    Bain BJ
    J Clin Pathol; 2009 Jan; 62(1):53-6. PubMed ID: 19103862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic carrier screening for hemoglobinopathies in the Netherlands is not opportune].
    Schulpen TW; van der Lee JH; van der Most van Spijk MW; Beemer FA
    Ned Tijdschr Geneeskd; 1998 May; 142(18):1019-22. PubMed ID: 9623203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MALDI-TOF MS profiling as the first-tier screen for sickle cell disease in neonates: matching throughput to objectives.
    Hachani J; Duban-Deweer S; Pottiez G; Renom G; Flahaut C; Périni JM
    Proteomics Clin Appl; 2011 Aug; 5(7-8):405-14. PubMed ID: 21751410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sickle cell disease as a public health problem in Brazil].
    de Paiva e Silva RB; Ramalho AS; Cassorla RM
    Rev Saude Publica; 1993 Feb; 27(1):54-8. PubMed ID: 8310270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of children with sickle cell disease in Africa: experience in a cohort of children at the Royal Albert Hospital in Dakar].
    Diagne I; Diagne-Gueye ND; Signate-Sy H; Camara B; Lopez-Sall P; Diack-Mbaye A; Sarr M; Ba M; Sow HD; Kuakuvi N
    Med Trop (Mars); 2003; 63(4-5):513-20. PubMed ID: 14763308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.